摘要
Metabolic reprogramming drives the development of an immunosuppressive tumor microenvironment (TME) through various pathways, contributing to cancer progression and reducing the effectiveness of anticancer immunotherapy. However, our understanding of the metabolic landscape within the tumor-immune context has been limited by conventional metabolic measurements, which have not provided comprehensive insights into the spatiotemporal heterogeneity of metabolism within TME. The emergence of single-cell, spatial, and in vivo metabolomic technologies has now enabled detailed and unbiased analysis, revealing unprecedented spatiotemporal heterogeneity that is particularly valuable in the field of cancer immunology. This review summarizes the methodologies of metabolomics and metabolic regulomics that can be applied to the study of cancer-immunity across single-cell, spatial, and in vivo dimensions, and systematically assesses their benefits and limitations.
学科与关键词
- Improving Cancer Immunotherapy: Exploring and Targeting Metabolism in Hypoxia MicroenvironmentWei, Jinfen; Hu, Meiling; Du, Hongli*Frontiers in Immunology, 2022, 13: 845923.被引 12
- The Development of Single-Cell Metabolism and Its Role in Studying Cancer Emergent PropertiesWei, Dingju; Xu, Meng; Wang, Zhihua; Tong, Jingjing*Frontiers in Oncology, 2022, 11: 814085.被引 6
- Progress in research on tumor microenvironment-based spatial omics technologiesXie, Fangmei; Xi, Naite; Han, Zeping; Luo, Wenfeng; Shen, Jian; Luo, Jinggeng; Tang, Xingkui; Pang, Ting; Lv, Yubing; Liang, Jiabing; Liao, Liyin; Zhang, Haoyu; Jiang, Yong; Li, Yuguang*; He, Jinhua*Oncology Research, 2023, 31(6): 885-885.
